Authors
Latest:
Two Sides of the Same Coin: A Randomized Clinical Trial of the Unified Protocol for Addressing Depression and Anxiety in People With Multiple SclerosisTransdiagnostic interventions, such as the Unified Protocol, address both depression and anxiety and focus on the shared temperamental core of psychological disorders, which have been shown to impact functional outcomes as well.
Latest:
The Application of Treatment Guidelines in Multiple Sclerosis Care: A Qualitative Analysis of Barriers and FacilitatorsMultiple sclerosis clinicians in Australia report that guideline application can improve standards of care but report varying practices in applying treatment guidelines.
Latest:
Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple SclerosisMore data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.
Latest:
The Emerging Role of Optogenetics in Multiple Sclerosis ResearchPossible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.
Latest:
Unspoken Challenges: Sexual Health in Sexual and Gender Minority People With Multiple SclerosisSexual and gender minority individuals with multiple sclerosis face additional challenges, including stigma, discrimination, and health care disparities, which can limit access to sexual health services, including family planning and gender-affirming care.
Latest:
Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple SclerosisMore data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.